Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

114 in total

Review 1. Therapeutic strategies to improve drug delivery across the blood-brain barrier.

Authors: Tej D Azad; James Pan; Ian D Connolly; Austin Remington; Christy M Wilson; Gerald A Grant
Journal: Neurosurg Focus Date: 2015-03 Impact factor: 4.047

2. Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.

Authors: Lei Shi; Xifeng Fei; Zhimin Wang
Journal: Tumour Biol Date: 2015-04-16

3. Role of rCBV values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging in differentiating CNS lymphoma from high grade glioma: a meta-analysis.

Authors: Ruofei Liang; Mao Li; Xiang Wang; Jiewen Luo; Yuan Yang; Qing Mao; Yanhui Liu
Journal: Int J Clin Exp Med Date: 2014-12-15

4. Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).

Authors: Mary Lou Affronti; Sarah Woodring; Karen Allen; John Kirkpatrick; Katherine B Peters; James E Herndon; Frances McSherry; Patrick N Healy; Annick Desjardins; James J Vredenburgh; Henry S Friedman
Journal: Support Care Cancer Date: 2016-06-06 Impact factor: 3.603

5. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.

Authors: Lei Shi; Zhimin Wang; Guan Sun; Yi Wan; Jun Guo; Xingli Fu
Journal: Neuromolecular Med Date: 2014-04-29 Impact factor: 3.843

6. Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Authors: Betty Y S Kim; Wen Jiang; Jason Beiko; Sujit S Prabhu; Franco DeMonte; Mark R Gilbert; Raymond Sawaya; Kenneth D Aldape; Daniel P Cahill; Ian E McCutcheon
Journal: J Neurooncol Date: 2014-04-29 Impact factor: 4.130

7. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.

Authors: Liang Leng; Xiaojun Zhong; Guan Sun; Wen Qiu; Lei Shi
Journal: Tumour Biol Date: 2016-10-18

Review 8. CD147 and glioma: a meta-analysis.

Authors: Hui Li; Zhouhuan Xi; Xuejiao Dai; Wenyue Wu; Yanwen Li; Yanting Liu; Hanwen Zhang
Journal: J Neurooncol Date: 2017-05-30 Impact factor: 4.130

9. Drug repurposing for glioblastoma based on molecular subtypes.

Authors: Yang Chen; Rong Xu
Journal: J Biomed Inform Date: 2016-09-30 Impact factor: 6.317

Review 10. The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience.

Authors: A Gutenberg; C B Lumenta; W E K Braunsdorf; M Sabel; H M Mehdorn; M Westphal; A Giese
Journal: J Neurooncol Date: 2013-03-28 Impact factor: 4.130